Belantamab Mafodotin Combo Shows PFS Improvement in R/R Multiple Myeloma

被引：0
作者：
不详
机构：
来源：
ONCOLOGY-NEW YORK | 2024年 / 38卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：44
相关论文
共 50 条
  • [1] Belantamab mafodotin in multiple myeloma
    Martino, Enrica Antonia
    Bruzzese, Antonella
    Iaccino, Enrico
    Labanca, Caterina
    Mendicino, Francesco
    Mimmi, Selena
    Lucia, Eugenio
    Olivito, Virginia
    Neri, Antonino
    Morabito, Fortunato
    Vigna, Ernesto
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (11) : 1043 - 1047
  • [2] Belantamab mafodotin for the treatment of multiple myeloma
    Wang, B.
    Wu, C.
    Zhong, Q.
    Ling, L.
    Wu, Z.
    Yu, B.
    Gao, X.
    Zeng, H.
    Yang, D-H
    DRUGS OF TODAY, 2021, 57 (11) : 653 - 663
  • [3] BELANTAMAB MAFODOTIN IN A PATIENT WITH REFRACTORY MULTIPLE MYELOMA
    Luz Gema, Roman
    Borja, Puertas
    Alberto, Hernandez
    Sandra, Gomez
    Felipe, Pena
    Danylo, Palomino
    Bea, Rey
    Marta, Fonseca
    Raul, Azibeiro
    Elena, Alejo
    David, Alonso
    Jose Maria, Navarro
    Veronica, Gonzalez
    Noemi, Puig
    Maria Victoria, Mateos
    HAEMATOLOGICA, 2021, 106 (10) : 334 - 334
  • [4] Belantamab mafodotin for relapsed or refractory multiple myeloma
    David Gil-Sierra, Manuel
    del Pilar Briceno-Casado, Maria
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (06) : 1375 - 1380
  • [5] Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma
    Dimopoulos, Meletios Athanasios
    Beksac, Meral
    Pour, Ludek
    Delimpasi, Sosana
    Vorobyev, Vladimir
    Quach, Hang
    Spicka, Ivan
    Radocha, Jakub
    Robak, Pawel
    Kim, Kihyun
    Cavo, Michele
    Suzuki, Kazuhito
    Morris, Kristin
    Pompilus, Farrah
    Phillips-Jones, Amy
    Zhou, Xiaoou L.
    Fulci, Giulia
    Sule, Neal
    Kremer, Brandon E.
    Opalinska, Joanna
    Mateos, Maria-Victoria
    Trudel, Suzanne
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (05) : 408 - 421
  • [6] Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
    Hungria, Vania
    Robak, Pawel
    Hus, Marek
    Zherebtsova, Vera
    Ward, Christopher
    Ho, P. Joy
    Ribas de Almeida, Ana Carolina
    Hajek, Roman
    Kim, Kihyun
    Grosicki, Sebastian
    Sia, Hanlon
    Bryant, Adam
    Pitombeira de Lacerda, Marcelo
    Aparecida Martinez, Gracia
    Sureda Balari, Anna Maria
    Sandhu, Irwindeep
    Cerchione, Claudio
    Ganly, Peter
    Dimopoulos, Meletios
    Fu, Chengcheng
    Garg, Mamta
    Abdallah, Al-Ola
    Oriol, Albert
    Gatt, Moshe E.
    Cavo, Michele
    Rifkin, Robert
    Fujisaki, Tomoaki
    Mielnik, Michal
    Pirooz, Nick
    Mckeown, Astrid
    Mcnamara, Simon
    Zhou, Xiangdong
    Nichols, Maureen
    Lewis, Eric
    Rogers, Rachel
    Baig, Hena
    Eccersley, Lydia
    Roy-Ghanta, Sumita
    Opalinska, Joanna
    Mateos, Maria-Victoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (05) : 393 - 407
  • [7] A Belantamab Mafodotin Revival in Multiple Myeloma Therapy
    Trudel, Suzanne
    Stewart, A. Keith
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (05) : 461 - 462
  • [8] Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
    Lucijanic, Marko
    Sabljic, Anica
    Krecak, Ivan
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (14) : 1364 - 1365
  • [9] Belantamab mafodotin in the treatment of relapsed or refractory multiple myeloma
    Sheikh, Semira
    Lebel, Eyal
    Trudel, Suzanne
    FUTURE ONCOLOGY, 2020, 16 (34) : 2783 - 2798
  • [10] The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
    McCurdy, Arleigh
    Visram, Alissa
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2022, 17 (06) : 306 - 318
12345